Trial Profile
Clinical Trials Insight: 700028571
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2007
Price :
$35
*
At a glance
- Drugs RAV 12 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Raven Biotechnologies
- 16 Nov 2007 New trial record.